<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-O44</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-O44</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Incidental lesion in oncology patients: kidneys</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Sohaib</surname><given-names>Aslam</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Dept. of Radiology, Royal Marsden Hospital, London &#x00026; Sutton, UK</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>O44</fpage><lpage>O44</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Sohaib; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Sohaib; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/O44"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title/><p>The increasing use of cross-sectional imaging has led to greater detection of incidental lesions in oncology and non-oncology patients. These incidental lesions are unexpected and usually asymptomatic abnormalities that are identified when imaging for other purposes. These incidental lesions create a diagnostic and management challenge for radiologists and clinicians [<xref ref-type="bibr" rid="B1">1</xref>]. They may result in patients having unnecessary investigations and treatment, which is not without risks or expense. The American College of Radiologists has developed guidelines and recommendations for incidentally detected lesions on abdominal imaging [<xref ref-type="bibr" rid="B2">2</xref>]. The guidance developed addresses incidental findings in the kidney, liver, adrenal glands and pancreas but does not deal specifically with cancer patients.</p><p>In the case of an incidentally detected renal lesion in a cancer patient, the incidental abnormality may represent metastatic disease, a second primary malignancy or a benign lesion. The diagnosis and management of such incidental findings will depend in part on the clinical setting, the pathology and stage of underlying primary malignancy and the imaging features of the incidental abnormality [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B6">6</xref>].</p><p>In terms of imaging characterisation many incidental kidney lesions can be fully characterised using ultrasound, CT or MRI. In characterising a renal mass, in general it is important to first ensure that the mass is not the result of non-neoplastic conditions that may mimic a tumour. For example focal bacterial pyelonephritis, pseudotumours such as columns of Bertin, hypertrophied tissue adjacent to scars, vascular anomalies, aneurysms and infarcts.</p><p>Further imaging characterisation may suggest that the lesion is a benign cystic renal tumour, i.e. Bosniak I or II lesions. If the lesion is solid, unless there are features in keeping with an angiomyolipoma (AML), it is usually not possible to differentiate benign from malignant primary tumour or metastases to the kidney. Therefore either cystic lesions or solid lesions in which malignancy cannot be excluded may need further assessment and this is an indication for a renal biopsy.</p><p>Metastases to the kidney are very uncommon. Renal metastases frequently do not present clinical symptoms and many patients have no haematuria. Traditionally, metastases to the kidney are thought to be multiple and bilateral, however descriptions are limited to case reports. The most common malignancies metastasing to the kidney are lung and breast cancer. Previous imaging or history is also useful in evaluating metastases to the kidney as there is often widespread metastatic disease with renal involvement. Isolated metastasis is very rare and may need a biopsy in order to distinguish it from primary renal neoplasm.</p></sec></body><back><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Sohaib</surname><given-names>SA</given-names></name><name><surname>Riddell</surname><given-names>AM</given-names></name><article-title>Incidental pelvic lesions in the oncology patient</article-title><source>Cancer Imaging</source><year>2011</year><volume>11</volume><issue>Spec No A</issue><fpage>S95</fpage><lpage>102</lpage><?supplied-pmid 22186028?><pub-id pub-id-type="pmid">22186028</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Berland</surname><given-names>LL</given-names></name><etal/><article-title>Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee</article-title><source>J Am Coll Radiol</source><year>2010</year><volume>7</volume><issue>10</issue><fpage>754</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.jacr.2010.06.013</pub-id><?supplied-pmid 20889105?><pub-id pub-id-type="pmid">20889105</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Silverman</surname><given-names>SG</given-names></name><etal/><article-title>Management of the incidental renal mass</article-title><source>Radiology</source><year>2008</year><volume>249</volume><issue>1</issue><fpage>16</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1148/radiol.2491070783</pub-id><?supplied-pmid 18796665?><pub-id pub-id-type="pmid">18796665</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Sohaib</surname><given-names>A</given-names></name><article-title>Incidental solid cystic renal lesion</article-title><source>Cancer Imaging</source><year>2012</year><volume>12</volume><fpage>385</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1102/1470-7330.2012.9034</pub-id><?supplied-pmid 23023378?><pub-id pub-id-type="pmid">23023378</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Willatt</surname><given-names>J</given-names></name><name><surname>Francis</surname><given-names>IR</given-names></name><article-title>Imaging and management of the incidentally discovered renal mass</article-title><source>Cancer Imaging</source><year>2009</year><volume>9</volume><issue>Spec No A</issue><fpage>S30</fpage><lpage>7</lpage><?supplied-pmid 19965291?><pub-id pub-id-type="pmid">19965291</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>O'Connor</surname><given-names>SD</given-names></name><name><surname>Pickhardt</surname><given-names>PJ</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Oliva</surname><given-names>MR</given-names></name><name><surname>Silverman</surname><given-names>SG</given-names></name><article-title>Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding management</article-title><source>AJR Am J Roentgenol</source><year>2011</year><volume>197</volume><issue>1</issue><fpage>139</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.2214/AJR.10.5920</pub-id><?supplied-pmid 21701022?><pub-id pub-id-type="pmid">21701022</pub-id></mixed-citation></ref></ref-list></back></article>
